By enabling self-loading of peptides, the ProVE SL platform empowers immunologists to adapt their reagents more quickly to new antigens, for example for infectious diseases, cancer neo-antigens, ...

Polyzos grew up in regional restaurants and rock bands, but it was his fascination with chemical reactions that birthed an entrepreneur ...